Common use of Rare Reagent Price Clause in Contracts

Rare Reagent Price. Within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gen-Probe an amount equal to [***] of the Manufacturing Cost for all Rare Reagents purchased by Chiron for use in manufacturing Initial Blood Screening Assays under Section 3.1.3(b) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.

Rare Reagent Price. Within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gen-Probe an amount equal to [***] of the Manufacturing Cost Costs for all Rare Reagents purchased by Chiron for use in manufacturing Initial Future Blood Screening Assays under Section 3.1.3(b3.2.4(b) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.

Rare Reagent Price. Within With respect to Rare Reagents manufactured sold by Gen-Probe to Chiron hereunder, within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gen-Probe an amount equal to [***] one hundred twenty percent (120%) of the Manufacturing Cost for all Rare Reagents purchased by Chiron for use in manufacturing Initial Blood Screening Exclusive Future Clinical Diagnostic Assays under Section 3.1.3(bSections 4.2.4(b) and 4.2.4(c) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.

Rare Reagent Price. Within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gen-Probe an amount equal to [***] one hundred twenty percent (120%) of the Manufacturing Cost for all Rare Reagents purchased by Chiron for use in manufacturing Initial Blood Screening Clinical Diagnostic Assays under Section 3.1.3(b4.1.3(b) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.

Rare Reagent Price. Within With respect to Rare Reagents sold by Gen-Probe to Chiron hereunder, within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gengen-Probe probe an amount equal to [***] one hundred twenty percent (120%) of the Manufacturing Cost manufacturing cost for all Rare Reagents rare reagents purchased by Chiron for use in manufacturing Initial Blood Screening nonexclusive future clinical Diagnostic Assays under Section 3.1.3(b4.3.4(a) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.

Rare Reagent Price. Within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gen-Probe an amount equal to [***CONFIDENTIAL TREATMENT REQUESTED] of the Manufacturing Cost Costs for all Rare Reagents purchased by Chiron for use in manufacturing Initial Future Blood Screening Assays under Section 3.1.3(b3.2.4(b) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.

Rare Reagent Price. Within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gen-Probe an amount equal to [***CONFIDENTIAL TREATMENT REQUESTED] of the Manufacturing Cost for all Rare Reagents purchased by Chiron for use in manufacturing Initial Blood Screening Assays under Section 3.1.3(b) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.